KOMIPHARM YET TO GET APPROVAL TO TEST PANAPHIX DRUG – COVID-19

Highlights –

• Market observers wait for Komipharm drug test approvals, hoping to invest in company shares
• Korea Exchange has warned against unchecked fluctuations in coronavirus-themed stocks
• The company experienced an upward streak in their stocks for five consecutive days

According to a report by The Korea Herald, Komipharm is confident about the upcoming develop....